Article: Six Planned Parenthood Affiliates to be Among Trial Sites for Mifepristone Abortion Method

NEW YORK, Oct. 27 /U.S. Newswire/ -- Six Planned Parenthood affiliates are among the several sites participating in clinical trials of the drug mifepristone (formerly known as RU-486) for use as a medical alternative to surgical abortion.

The Population Council, which holds the U.S. patent for the drug, announced the commencement of the clinical trials at a press conference earlier today.

"After years of effort to bring mifepristone to these shores -- and based on its successful use in Europe and China -- Planned Parenthood is proud to be among the first to provide this important option for American women on a trial basis," said Pamela J.

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!